Nagaraja Tavarekere N, Keenan Kelly A, Fenstermacher Joseph D, Knight Robert A
Department of Anesthesiology, Henry Ford Health System, Detroit, Michigan 48202, USA.
Microcirculation. 2008 Jan;15(1):1-14. doi: 10.1080/10739680701409811.
This study tested the hypothesis that blood-brain barrier (BBB) opening during acute reperfusion permits the passage of smaller macromolecules but not larger ones and that this molecular size restriction disappears over time.
Following 3 hours (h) of unilateral middle cerebral artery occlusion and either 3 or 21 h of reperfusion, Wistar rats (n = 42) were injected with Evans blue (EB, a fluorescent dye that binds instantly to plasma albumin yielding EB-tagged albumin, EB-Alb) and with one of three fluorescent dextrans ranging in size from 77- to 2000-kDa. During occlusion and reperfusion, ischemic status of the affected tissue was confirmed by magnetic resonance imaging (MRI). Blood-to-brain transfer of the dextrans relative to that of EB-Alb was examined by fluorescence microscopy within three regions with ischemic damage.
Increase in EB-Alb leakage from 3 to 21 h of reperfusion was significant (from 40-60% to 80-90% of fields examined; p < 0.05). Co-leakage of the largest dextran used 2000-kDa, with EB-Alb was observed in only 40% of the fields at 3+3 h, but nearly in all at 3 + 21 h (p < 0.01). Parenchymal distribution of the tracers differed among the fields and included considerable cellular uptake of EB-Alb and some of dextrans.
Supporting the hypothesis, opening of the BBB was insufficient to allow passage of the largest dextran at 3 + 3 h in about 40% of the microvascular networks viewed. The number of total leaky microvascular beds increased by nearly 50% between 3 + 3 h and 3 + 21 h.
本研究检验了以下假设,即急性再灌注期间血脑屏障(BBB)开放允许较小的大分子通过,但不允许较大的大分子通过,且这种分子大小限制会随时间消失。
在单侧大脑中动脉闭塞3小时(h)以及再灌注3或21小时后,给42只Wistar大鼠注射伊文思蓝(EB,一种能立即与血浆白蛋白结合产生EB标记白蛋白EB - Alb的荧光染料)和三种大小范围从77至2000 kDa的荧光葡聚糖之一。在闭塞和再灌注期间,通过磁共振成像(MRI)确认受影响组织的缺血状态。通过荧光显微镜在三个有缺血损伤的区域检查葡聚糖相对于EB - Alb的血脑转移情况。
再灌注从3小时到21小时,EB - Alb渗漏增加显著(从检查视野的40 - 60%增加到80 - 90%;p < 0.05)。在3 + 3小时时,所使用的最大葡聚糖(分子量2000 kDa)与EB - Alb的共同渗漏仅在40%的视野中观察到,但在3 + 21小时时几乎在所有视野中都观察到(p < 0.01)。示踪剂的实质分布在不同视野中有所不同,包括EB - Alb和一些葡聚糖有相当多的细胞摄取。
支持该假设的是,在3 + 3小时时,在约40%观察到的微血管网络中血脑屏障开放不足以允许最大的葡聚糖通过。在3 + 3小时和3 + 21小时之间,总的渗漏微血管床数量增加了近50%。